Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Cornerstone Therapeutics, Exela PharmSci Inc. cardiovascular news

August 5, 2013 7:00 AM UTC

Cornerstone filed a suit in the U.S. District Court for the District of Delaware alleging that an sNDA submitted by Exela for an injectable formulation of 0.1 and 0.2 mg/mL nicardipine in 0.9% sodium ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article